CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past? Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction 3D Printing and Heart Failure: The Present and the Future Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

Consensus2019 Sep 6. pii: S0167-5273(19)32502-1.

JOURNAL:Int J Cardiol. Article Link

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

Farmakis D, Agostoni P, Baholli L et al. Keywords: acute heart failure; advanced heart failure; dobutamine; inodilators; inotropes; levosimendan; milrinone; norepinephrine

FULL TEXT PDF